BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26868056)

  • 1. Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis.
    Pelucchi S; Galimberti S; Greni F; Rametta R; Mariani R; Pelloni I; Girelli D; Busti F; Ravasi G; Valsecchi MG; Valenti L; Piperno A
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1342-8. PubMed ID: 26868056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.
    Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J
    Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors.
    Greni F; Valenti L; Mariani R; Pelloni I; Rametta R; Busti F; Ravasi G; Girelli D; Fargion S; Galimberti S; Piperno A; Pelucchi S
    Ann Hepatol; 2017; 16(3):451-456. PubMed ID: 28425416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis.
    Buch S; Sharma A; Ryan E; Datz C; Griffiths WJH; Way M; Buckley TWM; Ryan JD; Stewart S; Wright C; Dongiovanni P; Fracanzani A; Zwerina J; Merle U; Weiss KH; Aigner E; Krones E; Dejaco C; Fischer J; Berg T; Valenti L; Zoller H; McQuillin A; Hampe J; Stickel F; Morgan MY
    Aliment Pharmacol Ther; 2021 Apr; 53(7):830-843. PubMed ID: 33565643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
    Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
    Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PNPLA3 and RNF7 Gene Variants are Associated with the Risk of Developing Liver Fibrosis and Cirrhosis in an Eastern European Population.
    Kupcinskas J; Valantiene I; Varkalaitė G; Steponaitiene R; Skieceviciene J; Sumskiene J; Petrenkiene V; Kondrackiene J; Kiudelis G; Lammert F; Kupcinskas L
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):37-43. PubMed ID: 28338112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis.
    Duarte TL; Caldas C; Santos AG; Silva-Gomes S; Santos-Gonçalves A; Martins MJ; Porto G; Lopes JM
    Redox Biol; 2017 Apr; 11():157-169. PubMed ID: 27936457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemochromatosis gene HFE Cys282Tyr mutation analysis in a cohort of Northeast German hospitalized patients supports assumption of a North to South allele frequency gradient throughout Germany.
    Meier P; Schuff-Werner P; Steiner M
    Clin Lab; 2005; 51(9-10):539-43. PubMed ID: 16285477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Simple RFLP-Based Method for
    Ogouma-Aworet L; Rabes JP; de Mazancourt P
    Biomed Res Int; 2020; 2020():9396318. PubMed ID: 33457423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
    Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
    Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced phenotypic expression in genetic hemochromatosis with time: Role of exposure to non-genetic modifiers.
    Deugnier Y; Morcet J; Lainé F; Hamdi-Roze H; Bollard AS; Guyader D; Moirand R; Bardou-Jacquet E
    J Hepatol; 2019 Jan; 70(1):118-125. PubMed ID: 30244162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetrance of the C28Y/C282Y genotype of the HFE gene.
    Asberg A; Hveem K; Kannelønning K; Irgens WØ
    Scand J Gastroenterol; 2007 Sep; 42(9):1073-7. PubMed ID: 17710673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.
    Barton JC; McLaren CE; Chen WP; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN; Adams PC; Phatak PD; Gurrin LC; Phillips JD; Parker CJ; Emond MJ; McLaren GD
    Ann Hepatol; 2018 Aug; 17(5):871-879. PubMed ID: 30145563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rs508487, rs236911, and rs236918 Genetic Variants of the Proprotein Convertase Subtilisin-Kexin Type 7 (
    Vargas-Alarcón G; Pérez-Méndez O; González-Pacheco H; Ramírez-Bello J; Posadas-Sánchez R; Escobedo G; Fragoso JM
    Cells; 2021 Jun; 10(6):. PubMed ID: 34207761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis.
    Olynyk JK; Grainger R; Currie H; Ramm LE; Ramm GA
    Sci Rep; 2023 May; 13(1):7775. PubMed ID: 37179448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
    Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
    Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based analysis of the frequency of HFE gene polymorphisms: Correlation with the susceptibility to develop hereditary hemochromatosis.
    Katsarou MS; Latsi R; Papasavva M; Demertzis N; Kalogridis T; Tsatsakis AM; Spandidos DA; Drakoulis N
    Mol Med Rep; 2016 Jul; 14(1):630-6. PubMed ID: 27221532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.